- Scheme Category:
- Equity Scheme >
NAV: ₹ 10.58 ↑ 0.38%
[as on 13 November, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of Invesco India Pharma and Healthcare Fund - Direct Plan - Growth and its peers as on 13 November, 2026
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | - | - | - | - | - |
Discrete returns (monthly)
| Month | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 | Oct 2026 |
|---|
| Returns | - | - | - | - | - | - | - | - | - | 1.46% |
NAV history
Invesco India Pharma and Healthcare Fund - Direct Plan - Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|
| 13 November, 2026 | 10.58 | 0.38% |
| 12 November, 2026 | 10.54 | 0.09% |
| 11 November, 2026 | 10.53 | 0.48% |
| 9 November, 2026 | 10.48 | 2.24% |
| 6 November, 2026 | 10.25 | 2.3% |
| 5 November, 2026 | 10.02 | -0.1% |
| 4 November, 2026 | 10.03 | 2.56% |
| 3 November, 2026 | 9.78 | 0.72% |
| 2 November, 2026 | 9.71 | 0.52% |
| 30 October, 2026 | 9.66 | 1.05% |
| 29 October, 2026 | 9.56 | 0.63% |
| 28 October, 2026 | 9.5 | 0.53% |
| 27 October, 2026 | 9.45 | 3.62% |
| 26 October, 2026 | 9.12 | 1.9% |
| 23 October, 2026 | 8.95 | -0.22% |
| 22 October, 2026 | 8.97 | 0% |
| 21 October, 2026 | 8.97 | -0.33% |
| 19 October, 2026 | 9 | -0.77% |
| 16 October, 2026 | 9.07 | -0.77% |
| 15 October, 2026 | 9.14 | 0% |
| 14 October, 2026 | 9.14 | -1.19% |
| 13 October, 2026 | 9.25 | -0.43% |
| 12 October, 2026 | 9.29 | -0.96% |
| 9 October, 2026 | 9.38 | 1.52% |
| 8 October, 2026 | 9.24 | -2.33% |
| 7 October, 2026 | 9.46 | -0.11% |
| 6 October, 2026 | 9.47 | 0.64% |
| 5 October, 2026 | 9.41 | -1.67% |
| 1 October, 2026 | 9.57 | -0.21% |
| 30 September, 2026 | 9.59 | |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Invesco India Pharma and Healthcare Fund - Direct Plan - Growth?
The latest NAV of Invesco India Pharma and Healthcare Fund - Direct Plan - Growth is 10.58 as on 13 November, 2026.
What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Invesco India Pharma and Healthcare Fund - Direct Plan - Growth?
Invesco India Pharma and Healthcare Fund - Direct Plan - Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
| Holding period | Tax rate |
|---|
| Less than 1 year (STCG) | 20% |
| More than 1 year (LTCG) | Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount. |